Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

160.17
+0.53000.33%
Post-market: 156.10-4.0700-2.54%19:59 EDT
Volume:2.23M
Turnover:356.02M
Market Cap:248.42B
PE:23.98
High:161.51
Open:161.43
Low:158.13
Close:159.64
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.64
T/O Rate:0.15%
Dividend:3.16
Dividend Rate:1.97%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.94
PE(LYR):24.49

Loading ...

Movement Alert|AstraZeneca PLC Falls 3.65% in After-Hours Trading, Disappointing Phase 3 Clinical Trial Results Weigh on Shares

Market Focus
·
Yesterday

Astrazeneca's Breast Cancer Drug Fails Late-Stage Trial

Reuters
·
Yesterday

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 11

European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading

MT Newswires Live
·
Sep 10

AstraZeneca (AZN) Receives a Buy from Berenberg Bank

TIPRANKS
·
Sep 10

AstraZeneca Shares Look Set for Swift Recovery

Dow Jones
·
Sep 09

AstraZeneca's COPD Drug Data to Boost Sales Outlook

Dow Jones
·
Sep 09

RBC Initiates AstraZeneca at Outperform With GBP145 Price Target

MT Newswires Live
·
Sep 09

RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 09

Dow Jones Top Company Headlines at 1 PM ET: Amazon Sued for Allegedly Discriminating Against Pregnant Workers | GE ...

Dow Jones
·
Sep 09

AstraZeneca Falls Tuesday, Underperforms Market

Dow Jones
·
Sep 09

Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon

MT Newswires Live
·
Sep 08

Dow Jones Top Company Headlines at 11 am ET: GE Aerospace to Buy Consolidated Precision Products | GameStop ...

Dow Jones
·
Sep 08

Amgen Says Phase 3 Study Meets Primary Endpoint in Small Cell Lung Cancer

MT Newswires Live
·
Sep 08

AstraZeneca Says Lung-Disease Drug Shows Benefits Across Patient Groups

Dow Jones
·
Sep 08

AstraZeneca Says Tozorakimab Cuts COPD Exacerbations in Phase 3 Trials

MT Newswires Live
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 08

AstraZeneca's Etcamah Opens New Breast-Cancer Treatment Paradigm

Dow Jones
·
Sep 07

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07